Advertisement

This Week in Diabetes News

Text Size:
Advertisement

Prevalence of Diabetes, Hypertension Among COVID-19 Patients Likely Lower Than Reported

Healio: “Risks for ICU admission and death from COVID-19 are higher for adults with diabetes and hypertension, but the number of COVID-19 patients with diabetes and hypertension may be lower than previously reported…” Click here for full story.

One Word Protects Your Brain from Diabetes and Dementia

Psychology Today: “You might not think that diabetes and dementia have anything in common. But they have a common risk factor when it comes to one protective behavior. And that’s our “one word” for the day…” Click here for full story.

Cardio Risk Increases With Diabetic Retinopathy Progression

Medscape: “The risk for heart attack, stroke, and even death increases as the severity of diabetic retinopathy increases. Severe retinopathy is linked to a doubling of the risk for cerebrovascular accident or myocardial infarction, results from a new study show…” Click here for full story.

Protecting Beta Cells Against Stress May Guard Against Type 1 Diabetes

Science Daily: “Researchers have found an unusual strategy that eventually may help to guard transplanted beta cells or to slow the original onset of type 1 diabetes…” Click here for full story.

Week of July 29, 2020

FDA Approves Non-Opioid Capsaicin Pain Patch for Diabetic Neuropathy

Healio: “The FDA approved an 8% capsaicin patch for the treatment of adults with neuropathic pain associated with diabetic peripheral neuropathy of the feet, according to an industry press release…” Click here for full story.

Why COVID-19 is Killing U.S. Diabetes Patients at Alarming Rates

Reuters: “Darrell Cager Sr., 64, had diabetes. So his youngest daughter urged him to seek care. The next day, he collapsed and died in his New Orleans home. The daughter soon learned the cause: acute respiratory distress from COVID-19...” Click here for full story.

Increased Blood Sugar Levels May Decrease Benefits of Aerobic Exercise

Science Daily: “Some benefits of aerobic exercise may be dampened by higher-than-normal blood sugar levels, a condition known as hyperglycemia. These diminished gains are seen in mouse models and humans with chronic hyperglycemia that is in the ‘prediabetes’ range...” Click here for full story.

Flu Shots Reduce All-Cause, CV Death for Adults With Diabetes

Healio: “Influenza vaccination was significantly associated with reduced risks for all-cause death, cardiovascular death, and death from acute myocardial infarction or stroke among adults with diabetes, according to an analysis of registry data...” Click here for full story.

Week of July 22, 2020

New Hampshire Law Caps Monthly Insulin Copay at $30

Healio: “New Hampshire GovChris Sununu signed into law an omnibus bill that will limit cost sharing for insulin to $30 for a 30-day supply for those with state-regulated commercial health insurance, according to a press release…” Click here for full story.

Simple Test Helps to Predict and Prevent Falls

Science Daily: “Scientists have developed a simple clinical test that can assess the lower limb strength of patients to predict their risk of falls. The ‘enhanced paper grip test’ involves pulling a small card from underneath the participant’s foot while asking them to grip with their big toe (Hallux)...” Click here for full story.

Is It Fair to Hope That Patients With Type 1 Diabetes (Autoimmune) May Be Spared by the Infection of Covid-19?

ScienceDirect: “The CoV-19 infection appears to be unusual among patients with type 1 Diabetes Mellitus, although they are considered a fragile population. We think that this in part due to the peculiar immune condition that leads to the destruction of the Beta cells…” Click here for full story.

Study Links Stress Hormone With Higher Blood Sugar in Type 2 Diabetes

Science Daily: “A new study by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine documents a clear link between the stress hormone cortisol and higher blood sugar levels in people with type 2 diabetes…” Click here for full story.

Week of July 15, 2020

Two More Drug Makers Recall Type 2 Diabetes Medication Metformin Over Cancer Concerns

1010 WINS: “Two more drug manufacturers have recalled the widely-used Type 2 diabetes medication metformin, over concerns that it contains too much of the human carcinogen NDMA, a ‘probable’ cancer-causing substance, the FDA announced this week...” Click here for full story.

Hyperglycemia Predicts COVID-19 Death Even Without Diabetes

Medscape: “Nearly half of hospitalized COVID-19 patients without a prior diabetes diagnosis have hyperglycemia, and the latter is an independent predictor of mortality at 28 days, new research indicates…” Click here for full story.

Can Other Drugs Added to Metformin Improve Outcomes in Type 2 Diabetes?

MedPage Today: “The goal of this study was to compare benefits and harms of different glucose-lowering drugs in adults with type 2 diabetes. Question Addressed: What were the benefits and harms of different glucose-lowering drugs in adults with type 2 diabetes?..” Click here for full story.

Coronavirus Damages the Endocrine System

Science Daily: “People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society...” Click here for full story.

Early Type 2 Diabetes Diagnosis Drives Long-Term Kidney Disease Risk

Healio: “Diabetic ketoacidosis is a common and potentially fatal complication in hospitalized patients with COVID-19, according to a new clinical perspective.Adults diagnosed with type 2 diabetes before age 30 years are more likely to develop renal failure over time compared with those with a shorter diabetes duration, according to a database analysis published in Diabetes Care...” Click here for full story.

Week of July 8, 2020

Is Metformin the Best First-Line Therapy for Those With Diabetes?

Medscape: “The largest network meta-analysis of diabetes drugs to date indirectly compared 21 glucose-lowering drugs for adults with type 2 diabetes in nine drug classes and 453 trials — to help guide therapy in a ‘challenging, complex landscape’…” Click here for full story.

Diabetic Ketoacidosis Threatens Hospitalized Patients With COVID-19

Science Daily: “Diabetic ketoacidosis is a common and potentially fatal complication in hospitalized patients with COVID-19, according to a new clinical perspective…” Click here for full story.

Machine-Learning Test May Improve Kidney Failure Prediction in Patients With Diabetes

Healio: “For patients with type 2 diabetes or the APOL1-HR genotype, a machine learning test integrating biomarkers and electronic health record data demonstrated improved prediction of kidney failure compared with commonly used clinical models….” Click here for full story.

Promising Treatment to Slow Kidney Disease Doesn’t Prove Out in Clinical Trial

Science Daily: “Progression of kidney disease in type 1 diabetes is correlated with increased amounts of uric acid. A drug that reduces uric acid levels was tested in a multi-institution randomized clinical trial. Though the study did not show the desired clinical benefit, it did provide a very clear answer to an important scientific question…” Click here for full story.

Week of July 1, 2020

Diabetes Drug May Lower COVID-19 Death Risk in Women

Medscape: “Women taking the widely used oral diabetes medication metformin may be at lower risk for fatal COVID-19, according to a study posted on Saturday that has not yet been peer-reviewed…” Click here for full story.

A Diabetes Drug That Slows Cognitive Decline?

MedPage Today: “Can a glucagon-like peptide-1 (GLP-1) receptor agonist lower cognitive decline in type 2 diabetes? An exploratory analysis of the dulaglutide (Trulicity) cardiovascular outcome trial suggests so…” Click here for full story.

Type 1 Diabetes Prevention Moves Toward Reality

Science Daily: “Prevention or delay of type 1 diabetes could become a reality in the next few years, with teplizumab (PRV-031, Provention Bio) likely to become the first agent commercially available to halt disease progression…” Click here for full story.

Signs of Being Prone to Adult Diabetes Are Already Visible at Age 8 Years Old

Science Daily: “Early signs of being more susceptible to type 2 diabetes as an adult can be seen in children as young as 8 years old, decades before it is likely to be diagnosed, according to a new study…” Click here for full story.

Week of June 24, 2020

Simplified Management Protocol Can Prevent, Treat DKA in COVID-19

Healio: “Alternative, patient-tailored strategies are needed to treat diabetic ketoacidosis in the setting of COVID-19 to better balance intensive insulin therapy with minimizing clinician exposure and preserving personal protective equipment…” Click here for full story.

FDA OKs Evoke Pharma’s Metoclopramide for Diabetic Gastroparesis

Seeking Alpha: “The FDA approves Evoke Pharma’s Gimoti (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis, a disorder in which the stomach’s contractions are disrupted compromising digestion…” Click here for full story.

Celiac Disease ‘Frequently’ Asymptomatic in Type 1 Diabetes

Healio: “Celiac disease as a comorbidity of type 1 diabetes is often asymptomatic, and people with both diseases should closely monitor glucose levels during transition to a gluten-free diet, according to a study…” Click here for full story.

Endogenous Insulin Production is Preserved in Type 1 Diabetes With Anti-TNF Drug

Science Daily: “Alternative, patient-tailored strategies are needed to treat diabetic ketoacidosis in the setting of COVID-19 to better balance intensive insulin therapy with minimizing clinician exposure and preserving personal protective equipment…” Click here for full story.

Diabetes Control in U.S. Youth Has Worsened Over Time

Medscape: “Glycemic control among youth with diabetes is no better today than it was in 2002 and in some subgroups it’s worse, despite increased availability of diabetes technology, newer therapies, and more aggressive recommended blood glucose targets, new research finds…” Click here for full story.

Week of June 17, 2020

COVID-19 May Trigger New Diabetes, Experts Warn

Science Daily: “Emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in healthy people and also cause severe complications of pre-existing diabetes…” Click here for full story.

Undiagnosed Liver Disease Common Among US Adults With Type 2 Diabetes

Healio: “Among U.S. adults with type 2 diabetes attending primary care and endocrinology clinics, less than 40% of those found to have liver fibrosis had elevated aspartate aminotransferase and alanine aminotransferase, according to study data…” Click here for full story.

High-Frequency Spinal Cord Stimulation Eases Diabetic Neuropathy Pain

Medscape: “The SENZA-PDN study results were presented as a late-breaking poster presentation at the virtual annual scientific sessions of the American Diabetes Association. Those results included 103 patients randomized to conventional medical management alone, and 113 who received medical management plus the spinal cord stimulator…” Click here for full story.

FDA Clears Next-Generation Integrated Continuous Glucose Monitor

Healio: “The FDA has cleared a next-generation integrated continuous glucose monitoring system for adults and children aged 4 years and older with diabetes, according to a press release from Abbott…” Click here for full story.

Week of June 10, 2020

Treating Endocrine Conditions In the Age of COVID-19: What Experts Have Learned

Healio: “Since early March, experts have undertaken a flurry of new study and guidance for treating endocrine conditions in the setting of COVID-19. Debate continues over the risks for worse disease outcomes, optimal management and best treatments…” Click here for full story.

Cannabis Gaining Acceptance as Treatment for Neuropathic Pain?

Medscape: “Experts may be moving toward accepting cannabis as a useful tool to treat neuropathic pain (NP), a recent debate on the topic suggests…” Click here for full story.

“Excretion of Sugar Into Stool”? New Action of Anti-Diabetic Drug Discovered

Science Daily: “A research team has discovered that metformin, the most widely prescribed anti-diabetic drug, causes sugar to be excreted in the stool. Taking advantage of the new bio-imaging apparatus PET-MRI, they revealed that metformin promotes the excretion of blood sugar from the large intestine into the stool. This is a completely new discovery that was not previously anticipated…” Click here for full story.

Week of June 3, 2020

FDA Requests Voluntary Recall of Contaminated Metformin Products

Healio: “The FDA has asked five drug manufacturers to voluntarily recall several lots of extended-release metformin after agency lab testing revealed unacceptable levels of the nitrosamine impurity N-Nitrosodimethylamine, or NDMA…” Click here for full story.

One in 10 Covid-19 Patients With Diabetes Die Within a Week, Study Finds

CNN: “One in 10 coronavirus patients with diabetes died within the first seven days of hospitalization, and one in five needed a ventilator to breathe, according to a new study by French researchers…” Click here for full story.

Lockdown Bonus: Tighter Glucose Control in Type 1 Diabetes

Medscape: “In the search for silver linings from the COVID-19 pandemic, this is at least a short-term one: adults with type 1 diabetes confined at home during quarantine were better able to keep their blood glucose levels in target range, according to two new studies…” Click here for full story.

Patients With Type 1 Diabetes Spend About $2,500 a Year in Health Care Costs

Medscape: “Adults and children with type 1 diabetes will spend an average of $2,500 a year out-of-pocket for health care – but insulin isn’t always the biggest expense – new research suggests…” Click here for full story.

Week of May 27, 2020

Poll Shows Americans Unaware of the Impact of COVID-19 on Kidney Health

Healio: “A new National Kidney Foundation-Harris poll on COVID-19 and kidney health indicates less than one in five Americans are aware that kidneys can fail due to coronavirus…” Click here for full story.

Dairy-Rich Diet Linked to Lower Risks of Diabetes and High Blood Pressure

Science Daily: “Eating at least two daily servings of dairy is linked to lower risks of diabetes and high blood pressure, as well as the cluster of factors that heighten cardiovascular disease risk (metabolic syndrome), finds a large international study…” Click here for full story.

Treatment Tips as COVID-19 Complicates CVD Management in Diabetes

Medscape: “A new article outlines the many ways in which the COVID-19 pandemic necessitates new considerations beyond traditional cardiovascular risk management in people with diabetes and offers suggestions for an optimal approach for those hospitalized with the infection…” Click here for full story.

Modified Smartphone Detects Early Signs of Diabetes-Induced Blindness

New Atlas: “One of the disastrous effects of diabetes is the harm it can cause to the retina, with this degeneration of blood vessels in the eye now the leading cause of new blindness in working-age adults. An international team of scientists has developed technology that could pick up this so-called diabetic retinopathy in its early stages, using a standard smartphone…” Click here for full story.

Week of May 13, 2020

New Research Explores Blueberries’ Positive Effects In Men With Type 2 Diabetes

PR Newswire: “A new research study published in Current Developments in Nutrition found that the equivalent of one cup of fresh blueberries, given as 22 g of freeze-dried blueberries, may beneficially affect areas of health in overweight men with type 2 diabetes…” Click here for full story.

FDA Approves Dapagliflozin for HFrEF Regardless of Diabetes Status

Healio: “AstraZeneca announced the FDA has approved its SGLT2 inhibitor dapagliflozin to reduce risk for CV death and HF hospitalization in patients with HF with reduced ejection fraction with and without type 2 diabetes…” Click here for full story.

The Links Between COVID-19 and Diabetes, Known and Unknown

Medscape: “The story of COVID-19 and the science behind the pandemic is evolving rapidly every day, with a flurry of publications in various clinical and preclinical journals. Here, I summarize the known and unknown links between diabetes and COVID-19, focusing on three pertinent clinical questions…” Click here for full story.

Possible Vaccine for Virus Linked to Type 1 Diabetes

Science Daily: “According to many observations, certain virus infections may play a part in the autoimmune attack that leads to type 1 diabetes. Researchers have now produced a vaccine for these viruses in the hope that it could provide protection against the disease…” Click here for full story.

Week of May 6, 2020

CDC Offers Guidance to Patients With Chronic Disease “Living With Uncertainty” During COVID-19

Healio: “Patients with chronic diseases aged older than 65 years, particularly those with cardiovascular disease or diabetes, are at significantly greater risk for acquiring COVID-19 and subsequent mortality from the virus, according to findings presented during a CDC webinar…” Click here for full story.

Certain Diabetes Drugs May Protect Against Serious Kidney Problems

Science Daily: “Use of sodium glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes may help to lower the risk of serious kidney problems, finds a study published by The BMJ today…” Click here for full story.

For People With Diabetes and COVID-19, Blood Sugar Control Is Key

Science Daily: “A new study adds to the evidence that people with type 2 diabetes (T2D) are at greater risk of a poor outcome should they become infected with the virus that causes COVID-19. But there is some encouraging news: people with T2D whose blood sugar is well controlled fare much better than those with more poorly controlled blood sugar…” Click here for full story.

Age-Related Muscle Loss May Drive Type 2 Diabetes Risk Among Men

Healio: “Older men with sarcopenia are more likely to develop type 2 diabetes during 15 years of follow-up compared with men who have more lean body mass, according to findings published in the Journal of the Endocrine Society...” Click here for full story.

Week of April 29, 2020

AstraZeneca Pilots Diabetes Drug as Potential COVID-19 Treatment

Reuters: “Britain’s AstraZeneca is testing a diabetes drug as a potential treatment for COVID-19 patients who also had existing heart and kidney problems, its second trial of an approved therapy to help treat the disease caused by the coronavirus…” Click here for full story.

Wearable Device Lets Patients With Type 2 Diabetes Safely Use Affordable Insulin Option

Science Daily: “Adults with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin (RHI) in a wearable, patch-like insulin delivery device called V-Go®…” Click here for full story.

“We Knew We Needed to Get Creative”: Inside Mount Sinai’s Effort to Make Glucose Management Safer During COVID-19

Healio: “The risk for severe COVID-19 complications is significantly higher for people with diabetes, and glucose management may play a vital role in disease outcomes. At the same time, careful monitoring of inpatient glucose can prove unsafe for clinicians and nurses…” Click here for full story.

COVID-19 Decimates Outpatient Visits

Medsacpe: “There has been a massive decline in outpatient office visits as patients have stayed home — likely deferring needed care — because of COVID-19, new research shows…” Click here for full story.

Week of April 22, 2020

What You Need to Know About COVID-19 If You Have Diabetes

Harvard Medical School: “Preliminary data from China suggest that people with diabetes and other preexisting conditions are more likely to experience serious complications and death from COVID-19 than people without diabetes and other conditions…” Click here for full story.

The New York Times: “Women born by cesarean section had a higher risk for developing Type 2 diabetes decades later…” Click here for full story.

“Insufficient evidence” to Recommend DPP-IV Inhibitor Treatment in Type 2 Diabetes With COVID-19

Healio: “Insulin — not DPP-IV inhibitors or GLP-1 receptor agonists — should be the agent of choice for the management of severely ill patients with diabetes and coronavirus infections; this position is supported by extensive historical experience and the increased adoption of continuous glucose monitoring, according to a literature review published in Endocrine Reviews…” Click here for full story.

Type 2 Diabetes: Too Much Glucagon?

Science Daily: “Patients with type 2 diabetes secrete not only too little insulin but also too much glucagon, which contributes to poor blood glucose control. A new study from Uppsala University suggests that this is because the glucagon-secreting α-cells have become resistant to insulin…” Click here for full story.

Week of April 15, 2020

COVID-19 and Diabetes: Patterns Emerge

Medscape: “Here is another update on what we know about COVID-19 in people with diabetes. The data that we have suggest that people with diabetes are actually not at increased risk for catching the novel coronavirus, but once they become infected, they may do less well, particularly if they’re in an ICU setting…” Click here for full story.

Why Is Coronavirus a Bigger Worry for People With Diabetes?

U.S. News & World Report: “If you or someone you love has diabetes, you’ve probably noticed that diabetes always pops up on lists of people at higher risk from COVID-19 infections. And you’ve probably wondered why…” Click here for full story.

Metformin Appears to Shield Diabetic Patients From Post-Op Death

MedPage Today: “In patients with type 2 diabetes undergoing surgery, metformin appeared to offer some protection against poor outcomes, researchers reported…” Click here for full story.

Adopting Vegetarian Diet Can Be Easy, Offer Cardiometabolic Benefits

Medscape: “Whether the motivation is animal or worker welfare, environmental sustainability, personal taste or something else, people with diabetes can safely adopt a plant-based diet. In fact, vegetarian and vegan eating patterns have been shown to improve cardiovascular disease and glucose management…” Click here for full story.

Evaluating Grip Strength to Identify Early Diabetes

Science Daily: “A new study reports valuable new grip strength metrics that provide healthcare practitioners with an easy-to-perform, time-efficient screening tool for type 2 diabetes (T2DM)…” Click here for full story.

Week of April 8, 2020

Researchers Warn Possible Coronavirus Treatment Hydroxychloroquine May Be Toxic When Combined With Diabetes Drug

Forbes: “Researchers have warned that hydroxychloroquine (HCQ) and chloroquine (CQ), two similar drugs repeatedly touted by President Trump to be promising treatments for COVID-19, may be toxic when combined with a common diabetes drug…” Click here for full story.

Individuals Taking Class of Steroid Medications at High Risk for COVID-19

Science Daily: “Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according to a new article…” Click here for full story.

Panic-Buying for Coronavirus Affects Diabetes Patients: They Can’t Find Rubbing Alcohol

USA Today: “While the masses hunt for toilet paper, Caroline Gregory and other people with diabetes are on a different mission: scouring stores for the rubbing alcohol or alcohol swabs needed to manage their disease…” Click here for full story.

“Pace of Change Is Dizzying”: Joslin Diabetes Center Navigates Shifts In Care Brought On By COVID-19

Healio: “The COVID-19 pandemic has forced health care institutions around the country and around the globe to change the way they practice medicine. Clinicians at Joslin Diabetes Center — the world’s largest diabetes research center, diabetes clinic and provider of diabetes education —ramped up the organization’s telehealth capabilities within a week’s time to provide remote care for routine and nonurgent appointments, while fielding questions from anxious patients about access to medications and risks for worse coronavirus complications that can come with poorly controlled diabetes…” Click here for full story.

Week of April 2, 2020

At Issue: How Endocrinologists, Diabetes Specialists Are Responding to COVID-19

Healio: “As the COVID-19 pandemic continues to worsen, endocrinologists are confronting changes large and small to the way they practice medicine. For some… it means navigating an unprecedented, nationwide shift to telemedicine and virtual communication, all while prioritizing the patients who still urgently need an in-person consultation and the risks that come with it…” Click here for full story.

Keep Calm: Under 25s With Diabetes Not Hospitalized Due to COVID-19

Medscape: “Reports from pediatric endocrinologists in COVID-19 hotspots globally indicate that children, adolescents, and young adults with diabetes have so far not shown a different disease pattern with the virus compared to children and younger people who do not have diabetes…” Click here for full story.

Better Controlled Diabetes is Associated With Preserved Cognitive Function After Stroke

Medical Xpress: “As the COVID-19 pandemic continues to worsen, endocrinologists are confronting changes large and small to the way they practice medicine. For some… it means navigating an unprecedented, nationwide shift to telemedicine and virtual communication, all while prioritizing the patients who still urgently need an in-person consultation and the risks that come with it…” Click here for full story.

Diabetes Increases Knee OA Pain Intensity, Worsens Mental Health

Healio: “Patients with knee osteoarthritis demonstrated higher average pain intensity and worse physical and mental health if they also have diabetes, according to data published in Arthritis Care & Research…” Click here for full story.

Week of March 25, 2020

Glucose Control Key With COVID-19 in Diabetes, Say Experts

Medscape: “Patients with diabetes may be at extra risk for coronavirus disease (COVID-19) mortality, and doctors treating them need to keep up with the latest guidelines and expert advice…” Click here for full story.

Congress Needs to Clear a Path for People Living With Diabetes to Stay Safe During Pandemic

The Hill: “While estimates suggest that hundreds of millions of Americans may contract the coronavirus, the complications experienced by those infected will vary widely. The whole point of ‘flattening the curve’ is to ensure that those who are most in need of medical resources — the elderly and those with underlying health conditions — can receive medical attention when they need it…” Click here for full story.

Type 1 Diabetes Is Not One But Two Distinct Conditions, Defined By Diagnosis Age

Healio: “Children who are diagnosed with type 1 diabetes under the age of seven have a different form (or ‘endotype’) of the condition compared with those diagnosed aged 13 or above, new research has shown…” Click here for full story.

FDA Rejects Lower-Dose Empagliflozin 2.5 mg for Type 1 Diabetes

Healio: “The FDA on Friday issued a complete response letter for a supplemental new drug application for a 2.5 mg dose of the SGLT2 inhibitor empagliflozin as an adjunct to insulin for adults with type 1 diabetes, according to a press release from Boehringer Ingelheim and Eli Lilly…” Click here for full story.

Week of March 18, 2020

Coronavirus Disease 2019 (COVID-19)

CDC.gov: “COVID-19 is a new disease and we are learning more about it every day. Older adults and people of any age who have serious underlying medical conditions may be at higher risk for more serious complications from COVID-19.  Based upon available information to date, those most at risk include…” Click here for full story.

CDC Tells People Over 60 or Who Have Chronic Illnesses Like Diabetes to Stock Up On Goods and Buckle Down for a Lengthy Stay at Home

CNBC: “Many Americans will be exposed to COVID-19 over the next year or so with many people in the U.S. getting sick, a top CDC official said Monday, recommending that people over 60 and anyone with chronic medical conditions buckle down for a lengthy stay home…” Click here for full story.

“Everyone With Diabetes” Must Prepare for COVID-19

Medscape: “I’ve been getting many calls from my patients with diabetes who are understandably concerned about COVID-19 and their risk, so I thought this would be an important topic for us to discuss…” Click here for full story.

Extra Insulin Supplies, Medications Advised for People With Diabetes in Wake of COVID-19

Healio: “As the country struggles to come up with a public health response to the novel coronavirus pandemic, endocrinologists are warning people with type 1 and type 2 diabetes of their increased susceptibility for contracting the disease and how to best be prepared with an adequate supply of diabetes medications and testing supplies…” Click here for full story.

Week of March 11, 2020

New Mexico Becomes Third State to Cap Monthly Insulin Costs

Healio: “New Mexico Gov. Michelle Lujan Grisham on Wednesday signed legislation capping monthly copayments for insulin at $25, the lowest copay cap introduced at the state level and the latest state effort to stem the rising cost of the drug, according to a press release from the governor’s office…” Click here for full story.

Virginia Lawmakers Pass One of the Lowest Insulin Price Cap in Nation at $50 a Month

The Hill: “Virginia lawmakers have passed a bill that will force insurers to cap insulin costs at $50 a month, sending the bill to Gov. Ralph Northam’s (D) desk for signature…” Click here for full story.

High Olive Oil Consumption Lowers Risk for Heart Disease

Healio: “Patients who consumed at least 7 g per day of olive oil had lower risk for CHD and total CVD compared with those who did not consume it, according to data presented at the American Heart Association Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Scientific Sessions…” Click here for full story.

Bariatric Surgery Improves Type 2 Diabetes, Study Finds

Medscape: “Patients with severe obesity and diabetes who are contemplating bariatric surgery now have data to make a better-informed decision, researchers report. A large, multicenter US study of such patients has identified similarities and differences in 5-year diabetes remission, diabetes relapse, and glycemic control after the two most common types of bariatric surgery…” Click here for full story.

Walking More Steps Daily Lowers Risk for Diabetes, Hypertension

Healio: “A higher volume of steps per day in middle-aged adults lowered the risk for type 2 diabetes and stage 2 hypertension, according to data presented at the American Heart Association Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Scientific Sessions…” Click here for full story.

Week of March 4, 2020

Metformin Add-On Ameliorates Weight Gain, Lowers Insulin Requirements in Type 1 Diabetes

Healio: “Chinese adults with type 1 diabetes can avoid insulin-related weight gain and use less insulin by adding metformin to treatment regimens, according to findings published in the Journal of Diabetes…” Click here for full story.

Could Resetting Our Internal Clocks Help Control Diabetes?

Science Daily: “The circadian clock system allows the organisms to adjust to periodical changes of geophysical time. Today, increasing evidence show that disturbances in our internal clocks stemming from frequent time zone changes, irregular working schedules or ageing, have a significant impact on the development of metabolic diseases including type-2 diabetes…” Click here for full story.

Two in Five Americans With Diabetes Report Financial Hardship

Medscape: “Americans with diabetes are experiencing more financial hardship from medical bills than those without diabetes, even when they have health insurance, new research shows…” Click here for full story.

Testing Lab Challenges FDA Findings That Carcinogens in Metformin Do Not Exceed Acceptable Levels

FiercePharma: “As questions about suspected carcinogens in drugs continue to roil the supply chain, the FDA last month said its testing of metformin did not find any with unacceptably high levels of NDMA. But testing laboratory Valisure has challenged those findings in a new Public Citizen petition, saying it discovered problems in 42% of the batches it checked. It contends the situation is likely to get worse as the COVID-19 outbreaks wreak havoc on supply chains…” Click here for full story.

Week of February 26, 2020

Regular Thyroid Testing Recommended Regardless of Diabetes Type

Healio: “Thyroid dysfunction is common among people with diabetes regardless of type, suggesting that biochemical thyroid screening should be a part of routine management for those with type 1 and type 2, according to an analysis of a community-based study published in Clinical Endocrinology…” Click here for full story.

Memory Games: Eating Well to Remember

Science Daily: “A healthy diet is essential to living well, but should we change what we eat as we age? Researchers have found strong evidence of the link between food groups and memory loss and its comorbidities. Her findings point to a need for age-specific dietary guidelines as the links may vary with age — people aged 80+ with a low consumption of cereals are at highest risk of memory loss and comorbid heart disease…” Click here for full story.

FDA Grants Dulaglutide CV Indication for Diabetes With or Without Established CVD

Healio: “The FDA approved the GLP-1 receptor agonist dulaglutide for the reduction of major adverse cardiovascular events for adults with type 2 diabetes who have established cardiovascular disease or multiple CV risk factors, making it the first type 2 diabetes drug approved for primary and secondary prevention populations, according to a press release from Eli Lilly…” Click here for full story.

Longer Breastfeeding, Lower Type 2 Risk After Gestational Diabetes

Medscape: “Among women with a history of gestational diabetes, a longer period of breastfeeding was associated with a lower probability of going on to develop type 2 diabetes, as well as a more favorable glucose metabolic biomarker profile. Women who breastfed for 2 years or longer had a 27% lower risk than that of those who did not breastfeed at all…” Click here for full story.

Week of February 19, 2020

Novel Once-Daily Pill Reduces HbA1c In Type 1 Diabetes

Healio: “An investigational, once-daily pill added to optimized insulin therapy was shown to reduce HbA1c among adults with type 1 diabetes during a 12-week trial when compared with placebo plus insulin, according to a press release from vTv Therapeutics…” Click here for full story.

The Skinny On Why Poor Sleep May Increase Heart Risk In Women

Science Daily: “Women who sleep poorly tend to overeat and consume a lower-quality diet, according to a new study from researchers at Columbia University Irving Medical Center. The findings provide new insight into how poor sleep quality can increase the risk of heart disease and obesity and points to possible interventions for improving women’s heart health…” Click here for full story.

Weight-Loss That Remits Type 2 Diabetes Normalizes Beta-Cell Function

Healio: “Adults with type 2 diabetes who lose enough weight to enter diabetes remission are also able to recapture normal beta-cell capacity, according to findings published in Diabetes Care…” Click here for full story.

Good News for Those With Type 2 Diabetes: Healthy Lifestyle Matters

Harvard Health News: “A recent study published in JAMA Cardiology looked at whether the ideal cardiovascular (CV) metrics covered in Life’s Simple 7 translate into improved CV health for those with T2D or prediabetes. The results were exciting, and consistent with other large population-based studies…” Click here for full story.

Week of February 11, 2020

FDA Not Recommending Recalls of Diabetes Drug Metformin

Medscape: “The US Food and Drug Administration (FDA) says it has no plans to recall any metformin products, used for the treatment of type 2 diabetes, after tests it conducted did not show any evidence of contamination with N-nitrosodimethylamine (NDMA) at levels that would cause concern…” Click here for full story.

New Study Adds to Evidence of Diabetes Drug Link to Heart Problems

Science Daily: “A new study published by The BMJ today adds to evidence that rosiglitazone — a drug used to treat type 2 diabetes — is associated with an increased risk of heart problems, especially heart failure…” Click here for full story.

VA Tests Keto Diet in Diabetic Patients; Skeptics Raise Red Flags

Medscape: “A partnership between the Department of Veterans Affairs and Silicon Valley startup Virta Health Corp. is focusing attention on the company’s claim that it provides treatment ‘clinically-proven to safely and sustainably reverse type 2 diabetes’ without medication or surgery…” Click here for full story.

CBT Program “Works wondersW for Patients With Diabetes

Healio: “A peer-delivered, cognitive behavioral therapy-based intervention improved functioning, pain, quality of life and self-reported physical activity in patients with diabetes and chronic pain, researchers reported in Annals of Family Medicine…” Click here for full story.

Week of February 5, 2020

CVS Announces Plan to Eliminate Co-Pays for Diabetes Drugs

Healio: “In hopes of helping ensure patients can take their medication as prescribed, CVS Caremark is offering employers and health insurers a solution that will eliminate out-of-pocket expenses for members, without costing either the employer or insurer more money…” Click here for full story.

Eli Lilly to Donate 200,000 Insulin Pens to Relief Organizations

Healio: “Eli Lilly and Co. will donate at least 200,000 KwikPens to three relief organizations to stock insulin at nearly 200 free clinics in the United States through 2022, according to an industry press release…” Click here for full story.

Could Resetting Our Internal Clocks Help Control Diabetes?

Medical Xpress: “The circadian clock system allows organisms to anticipate periodic changes of geophysical time and to adjust to those changes… Today, increasing evidence show that disturbances in internal clocks stemming from frequent time zone changes, irregular work schedules and aging have a significant impact on the development of metabolic diseases in human beings, including type-2 diabetes…” Click here for full story.

Keto Diet Works Best In Small Doses, Mouse Study Finds

Science Daily: “A ketogenic diet — which provides 99 percent of calories from fat and only 1 percent from carbohydrates — produces health benefits in the short term, but negative effects after about a week, researchers found in a study of mice…” Click here for full story.

Week of January 29, 2020

Saying ‘Diabetes Doesn’t Discriminate,’ Gov. J.B. Pritzker Signs Measure Limiting Out-of-Pocket Cost of Insulin to $100 for 30-Day Supply

Chicago Tribune: “Illinois became one of the first states in the U.S. to limit the out-of-pocket price of insulin when Gov. J.B. Pritzker signed a measure on Friday that caps the cost of medication people with diabetes rely on.” Click here for full story.

Eli Lilly Unveils Another Round of Lower-Cost Insulin Products

Biospace: “Eli Lilly is adding additional reduced cost insulin options to patients. The Indianapolis-based company announced lower-priced versions of Humalog Mix75/25 KwikPen (insulin lispro protamine and insulin lispro injectable suspension 100 units/mL) and Humalog Junior KwikPen (insulin lispro injection 100 units/mL).” Click here for full story.

Meijer Ends Free Medication Program for Diabetes, High Cholesterol

Crain’s Detroit Business: “Meijer Pharmacy has stopped offering two medications for free: type 2 diabetes drug metformin and cholesterol-lowering atorvastatin. The Grand Rapids-based pharmacy…said it will continue to offer the most commonly prescribed antibiotics along with prenatal vitamins for no charge to all customers.” Click here for full story.

HbA1c Testing in Barbershops Could Help Identify Undiagnosed Diabetes in Black Men

Healio: “Community-based HbA1c testing in barbershops may help identify black men with undiagnosed diabetes, according to a research letter published in JAMA Internal Medicine.Click here for full story.

Week of January 22, 2020

Fitness More Important Than Low BMI for Reducing Mortality Risk Among Adults With Diabetes

Healio: “Adults with diabetes of any BMI have lower mortality risk if they are more physically fit, although the “obesity paradox” still holds for less fit people, according to findings published in Diabetes Care...” Click here for full story.

Is Alzheimer’s Type 3 Diabetes? Novo Nordisk Is Willing to Find Out

BioSpace: “Danish company Novo Nordisk specializes in the diabetes market. The company appears to be making an entry into the Alzheimer’s market, which isn’t as unusual or unexpected as it initially sounds. It has been postulated for some time that Alzheimer’s disease is related to blood glucose levels and has been dubbed type 3 diabetes…” Click here for full story.

Early Action Required for Prevention, Management of Fatty Liver in Type 2 Diabetes

Healio: “Nonalcoholic fatty liver disease, or NAFLD, a condition traditionally treated by hepatologists, is widespread and frequently associated with obesity, insulin resistance, diabetes and other metabolic risk factors. Type 2 diabetes appears to worsen the course of NAFLD and promote development of nonalcoholic steatohepatitis, or NASH, the more severe form of the disease…” Click here for full story.

Can People with Diabetes Eat Dates?

Healthline: “Dates are the sweet, fleshy fruits of the date palm tree. They’re typically sold as dried fruit and enjoyed on their own or in smoothies, desserts, and other dishes. Due to their natural sweetness, their impact on blood sugar may be a concern for those with diabetes…” Click here for full story.

Diabetes Management Gains FDA Attention: 3 Stocks in Focus

Yahoo! Finance: “The FDA has of late been prioritizing approvals for the new-generation and advanced line of diabetes management devices… While diabetes management companies are coming up with cutting-edge innovation to gain traction in this niche market, there are a few stocks that deserve investors’ attention now. Let us take a closer look.” Click here for full story.

Top 5 Diabetes Highlights From 2019

Medscape: “Ever since the U.S. Food and Drug Administration (FDA) mandated cardiovascular outcome trials (CVOTs) for all diabetes medications, these trials have hogged the limelight in diabetes-related news… But now, for the first time in several years, an FDA-mandated CVOT is not leading the list of the year’s top diabetes news!” Click here for full story.

Week of January 15, 2020

Need to Control Blood Sugar? There’s a Drink for That

Science Daily: “With more people with diabetes and pre-diabetes looking for novel strategies to help control blood sugar, new research suggests that ketone monoester drinks — a popular new food supplement — may help do exactly that…” Click here for full story.

Gestational Diabetes May Heighten Type 2 Diabetes Risk Decades After Pregnancy

Healio: “Type 2 diabetes risk may be higher even after more than 20 years for Chinese women who develop gestational diabetes compared with those who do not, according to findings published in the Journal of Diabetes Investigation…” Click here for full story.

Neuropathic Therapy Center Seek Participants for Diabetic Peripheral Neuropathy Study

Loma Linda University Health: “Loma Linda University Health is seeking volunteers with moderate to severe below-ankle neuropathy for a graduate student research study titled The Effect of Intraneural Facilitation Therapy on Diabetic Patients with Peripheral Neuropathy. The study hypothesizes that Intraneural Facilitation therapy (INF™) — a treatment that uses three physical holds to stretch specific nerve areas and bring pressurized blood flow to damaged nerves — may relieve patients with diabetic neuropathy of pain and discomfort…” Click here for full story.

Week of January 8, 2020

Novo Nordisk to Offer Free Insulin to U.S. Patients in Immediate Need

Reuters: “Novo Nordisk said on Thursday it would offer free, one-time supply of insulin to people in immediate need and at risk of rationing the medication, the rising price of which has attracted fierce criticism from lawmakers and regulators…” Click here for full story.

FDA Approves Rapid-Acting Insulin for Children With Diabetes

Healio: “The FDA on Monday approved fast-acting insulin aspart 100 U/mL as a mealtime insulin for children with diabetes, according to a press release from Novo Nordisk. Fast-acting insulin aspart (Fiasp) is the first and only fast-acting mealtime insulin injection that does not have a premeal dosing recommendation, according to Novo Nordisk…” Click here for full story.

Mediterranean Diet Repeats as Best Overall of 2020

Medscape: “For the third year in a row, the Mediterranean diet has been named the best diet overall in the U.S. News & World Report annual rankings. In 2018, the Mediterranean diet shared top honors with the DASH (Dietary Approaches to Stop Hypertension) diet…” Click here for full story.

Addition of Linagliptin to Metformin Reduces Prediabetes Progression

Healio: “Prediabetes was less likely to progress to type 2 diabetes among adults who took a combination of linagliptin and metformin vs. metformin alone; the combination group was also more likely to achieve normal glucose levels, according to findings published in Metabolism…” Click here for full story.

Five Myths About Diabetes

The Washington Post: “No, you don’t get it from eating too many sweets. More than 100 million U.S. adults live with diabetes or prediabetes, making the disease one of the most serious health risks in modern society…” Click here for full story.

Simple Type 2 Diabetes Treatment With Low Calorie Diet is So Effective, It Reverses the Disease in Studies

Good News Network: “A ‘breakthrough’ treatment plan for type-2 diabetes has the British National Health Service (NHS) bustling as they position themselves to adopt a new standard of treatment. The course of treatment consists of a liquid diet of 800 calories to be taken as a soup or shake daily for a set amount of months depending on the time since the patient developed type-2 diabetes…” Click here for full story.

New Automated Insulin Dosing System Hailed as a Breakthrough for Diabetics

Boston Herald: “An artificial pancreas system that automatically monitors and regulates blood glucose levels will reduce constant worry and self-care for Type 1 diabetes patients and is being hailed as a breakthrough by one of Boston’s top diabetes doctors…” Click here for full story.

Week of December 20, 2019

FDA Approves New Closed-Loop Insulin Delivery System for People With Type 1 Diabetes

The Verge: “A new software system that will let people with diabetes customize their treatment and automatically adjust their insulin levels was just approved for use by the Food and Drug Administration. It will reach patients in January 2020…” Click here for full story.

Ultra-Processed Foods Now Linked to Risk of Type 2 Diabetes

Medscape: “High consumption of so-called ultra-processed foods is associated with an increased risk of type 2 diabetes, independent of other risk factors including weight and nutritional quality of the diet, a new study indicates. The results suggest a possible modifiable target for prevention of diabetes, say the authors…” Click here for full story.

Noninjectable Options to Deliver Insulin, Manage Diabetes

Healio: “Several cutting-edge advances in noninjectable insulin delivery methods could offer new ways for people with diabetes to manage the disease and better control glucose response, with the possibility of an oral insulin formulation closer than ever before to becoming reality, according to a speaker at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease…” Click here for full story.

Brain Function Abnormal In Children With Type 1 Diabetes

Science Daily: “Children with Type 1 diabetes show subtle but important differences in brain function compared with those who don’t have the disease, a study led by researchers at the Stanford University School of Medicine has shown…” Click here for full story.

CDC Says Prediabetes Common In Teens and Young Adults

MedPage Today: “Prediabetes has frequently been linked with insulin resistance syndrome (metabolic syndrome), which, in turn, is directly involved in the pathogenesis of type 2 diabetes. The three glucose abnormality phenotypes of prediabetes have also been associated with an increased risk for cardiovascular disease (CVD)…” Click here for full story.

Is Coconut Water Good for Diabetes?

Healthline: “Sometimes called “nature’s sports beverage,” coconut water has gained popularity as a quick source of sugar, electrolytes, and hydration. It’s a thin, sweet liquid, extracted from the inside of young, green coconuts. Unlike coconut meat, which is rich in fat, coconut water consists mostly of carbs…” Click here for full story.

Teen Living With Diabetes Surprised With a Service Dog

Yahoo! News: “For many with diabetes, living a normal life can be difficult. And for families with children who may have the disease, it can be scary too. When 16-year-old Emily Setterstrom was diagnosed with Type 1 diabetes in kindergarten after suddenly experiencing rapid weight loss, her mom Jennifer Setterstrom, feared for her daughter’s life after losing her brother to the same disease…” Click here for full story.

Week of December 11, 2019

Diabetes Drug Has Unexpected, Broad Implications for Healthy Aging

Science Daily: “Metformin is the most commonly prescribed type 2 diabetes drug, yet scientists still do not fully know how it works to control blood sugar levels. Researchers have now used a novel technology to investigate why it functions so well. The findings could also explain why metformin has been shown to extend health span and life span in recent studies…” Click here for full story.

Low-Dose Aspirin Fails to Lower Dementia Risk Among All Adults With Type 2 Diabetes, But May Benefit Women

Healio: “Japanese adults with type 2 diabetes assigned a long-term low-dose aspirin regimen did not lower their risk for dementia vs. similar adults who did not routinely take aspirin, according to a post hoc analysis of the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes trial…” Click here for full story.

Intermittent Fasting Promotes Weight Loss, Improves Lipids

Medscape: “Limiting food consumption to a 10-hour window each day promotes weight loss and improves cardiometabolic abnormalities in women with metabolic syndrome, a small pilot study suggests…” Click here for full story.

New Diet That Matches Biological Clock May be Better for Diabetes

Medical News Today: “Typically, doctors advise people with type 2 diabetes to eat about six times a day. But this approach can lead to a vicious cycle in which individuals require more intensive treatments. Could a different approach to diet be more suitable?” Click here for full story.

85-Year-Old Man With Type 1 Diabetes Shatters Expectations

WNDU News: “There are more than a million people who have Type 1 diabetes, and they’re expected to live at least 10 years less than Americans without it. In fact, there are only 90 diabetics who have lived more than 70 years. But one man crushed that goal 15 years ago and is telling others how they can do it too…” Click here for full story.

Study Reveals How Diabetes Drug Promotes Healthy Aging

Medical News Today: “Doctors commonly prescribe metformin to help people with type 2 diabetes lower their blood sugar levels. The drug increases insulin sensitivity through its effects on glucose metabolism…” Click here for full story.

Week of December 4, 2019

FDA Approves Higher-Dose Insulin Glargine for Children With Diabetes

Healio: “The FDA on Tuesday approved an expanded indication for insulin glargine injection 300 U/mL to improve glucose response in children aged 6 years and older with diabetes, according to a press release from Sanofi. Insulin glargine injection (Toujeo) 300 U/mL is a long-acting insulin previously approved to improve blood glucose in adults with diabetes…” Click here for full story.

AI Screening for Diabetic Retinopathy Moves to Retail Clinics

Medscape: “Retail health clinics have been part of the trend in making healthcare more convenient, and now another option is being offered — testing for diabetic retinopathy. However, an ophthalmologist won’t make the diagnosis at the clinic; instead, it will be made by an artificial intelligence (AI) system called IDx-DR…” Click here for full story.

Chargers Quarterback Philip Rivers and Wife Tiffany Open Up About Son’s Type 1 Diabetes Diagnosis

People: “Los Angeles Chargers quarterback Philip Rivers and wife Tiffany Rivers are hoping to raise awareness for type 1 diabetes after their son was diagnosed with the condition when he was just 5 years old. ‘It’s our everyday,’ Tiffany tells PEOPLE of her son, Gunner, being diagnosed with the condition six years ago. ‘It’s our normal. It’s definitely a part of our life now’…” Click here for full story.

Helper Protein Worsens Diabetic Eye Disease

Science Daily: “In a recent study using mice, lab-grown human retinal cells and patient samples, scientists say they found evidence of a new pathway that may contribute to degeneration of the light sensitive tissue at the back of the eye…” Click here for full story.

Unexpected Viral Behavior Linked to Type 1 Diabetes in High-Risk Children

Medical Xpress: “New results from The Environmental Determinants of Diabetes in the Young (TEDDY) study show an association between prolonged enterovirus infection and the development of autoimmunity to the insulin-producing pancreatic beta-cells that precedes type 1 diabetes (T1D). Notably, researchers also found that early adenovirus C infection seemed to confer protection from autoimmunity. The full findings were published Dec. 2 in Nature Medicine…” Click here for full story.

Biosensor-Equipped Glasses Could Monitor Diabetes Through Tears

TNW: “Brazilian and US scientists have developed a glasses-based biosensor capable of measuring blood glucose levels through a person’s tears, offering a less invasive test for diabetics. Glucose levels need to be frequently monitored in people with diabetes, a disease that affects 62 million people in the Americas and 380 million worldwide…” Click here for full story.

Week of November 26, 2019

The Costly, Life-Disrupting Consequences of Poor Diabetes Care

The New York Times: “Diabetes, whether Type 1 or Type 2, may be the most underappreciated, misunderstood and poorly treated of all common medical problems, and many of the more than 30 million Americans affected by it are paying dearly with their health and lives as a result. Contrary to what many people think, diabetes is not just a disease of abnormal blood sugar control caused by a lack of insulin or an inadequate response to this crucial hormone…” Click here for full story.

TB Drug Helps in Diabetic Foot Osteomyelitis

Medpage Today: “Patients with diabetic foot osteomyelitis (DFO) treated with rifampin (Rifadin) experienced better outcomes than those treated with other antibiotics, authors of a retrospective cohort study reported. In approximately 6,000 patients followed for 2 years, 26.9% of those who received an antibiotic combination including rifampin — best known as a tuberculosis treatment — died or had an amputation compared with 37.2% of those who received antibiotics other than rifampin (P=0.02)…” Click here for full story.

If You Have Type 2 Diabetes, You’re at Much Greater Risk for Fatty Liver Disease

Miami Herald: “For many years, Abraham Aviv had suffered from nonalcoholic fatty liver disease… Non-alcoholic fatty liver disease is common in the type 2 diabetic population, said Dr. Kawtar Al Khalloufi, a hepatologist at Cleveland Clinic Florida-Weston, where Aziz was referred after being diagnosed with cirrhosis…” Click here for full story.

As Diabetes Technologies Advance, Matching Patients to the “Right” Device Challenges Providers

Healio: “Diabetes devices such as sensors, insulin pumps and continuous glucose monitors continue to improve, offering people with diabetes more opportunities for connected care… As new devices and updates for older technologies enter the market, endocrinologists, diabetes care and education specialists, and other providers can find themselves overwhelmed…” Click here for full story.

Week of November 20, 2019

Life Experience Critical for Managing Type 2 Diabetes

Science Daily: “Researchers found that age plays a critical role in the well-being of people newly diagnosed with Type 2 diabetes, with younger patients more susceptible to psychological distress resulting in worse health outcomes…” Click here for full story.

FDA Panel Rejects Empagliflozin for Use in Type 1 Diabetes

Medscape: “A U.S. Food and Drug Administration (FDA) advisory committee has recommended against approval of empagliflozin (Boehringer Ingelheim, Jardiance), a sodium-glucose cotransporter type 2 (SGLT2) inhibitor, as an adjunct to insulin therapy to improve glycemic control in adults with type 1 diabetes mellitus…” Click here for full story.

Oramed Announces Successful Phase IIB Study of Oral Insulin in Type 2 Diabetes

Oramed: “Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced positive results from the initial cohort of the Phase IIb trial evaluating the efficacy and safety of its lead oral insulin candidate, ORMD-0801, which has the potential to be the first commercial oral insulin capsule for the treatment of diabetes…” Click here for full story.

Multiple Type 2 Diabetes Benefits Achievable Through Low-Carb Diets

Healio: “Adults with type 2 diabetes can experience multiple diabetes-specific benefits beyond weight loss by undertaking a low-carbohydrate diet, although potential risks must be addressed, according to a speaker at ObesityWeek…” Click here for full story.

Sky-High Insulin Costs Force Diabetic Patients to Ration the Life-Saving Medication

ABC 7: “Rationing insulin is not uncommon among people with diabetes. The average price of the drug has skyrocketed in recent years, leading some patients to go to desperate lengths to get it. The American Diabetes Association (ADA) reports the price of the drug has nearly tripled between 2002 and 2013…” Click here for full story.

Diabetes Tougher on Women’s Hearts

WebMD: “Diabetes might be more deadly for women than men, at least when it comes to heart troubles, new research showsHeart disease occurs an average of 15 years earlier in people with diabetes, and is their main cause of illness an death. In women, the connection between diabetes and heart disease is particularly strong…” Click here for full story.

There Are 4 Ways to Manage Your Type 1 Diabetes Through Treatment — Here’s How

Health.com: “Only about 5% of those diagnosed with diabetes have type 1, which is why it may seem like this version of the disease seems a little more mysterious than type 2 diabetes—and with good reason: No one knows quite how to prevent type 1 diabetes yet, according to the Centers for Disease Control and Prevention (CDC)…” Click here for full story.

Week of November 13, 2019

Diabetes More Effectively Treated With Immediate Sitagliptin, Metformin Combination Therapy

Healio: “Insulin is needed less frequently and HbA1c is lowered more robustly when adults with type 2 diabetes do not delay combination therapy but begin treatment by taking sitagliptin and metformin together, according to findings published in Diabetic Medicine…” Click here for full story.

‘Best-in-Class’ Diabetes Drugs Compared in Head to Head Trial

Medscape: “Oral semaglutide (Rybelsus, Novo Nordisk) lowered hemoglobin A1c more than empagliflozin (Jardiance, Boehringer Ingelheim/Lilly) in a recently published open-label, head-to-head comparison of the type 2 diabetes drugs…” Click here for full story.

Diabetic Foot Ulcers: A Silent Killer of Veterans

STAT: “Veterans who survive the horrors of war or the other dangers of military service often die years later from a silent but deadly scourge: diabetic foot ulcers, open sores or lesions that typically start on the bottom of the foot…” Click here for full story.

Bariatric Surgery Complications More Common With Higher Preoperative HbA1c

Healio: “Adults who undergo bariatric surgery may be more likely to be readmitted to the hospital, have more trips to the ICU and have a higher rate of overall morbidity if they have an HbA1c of more than 7% before surgery, according to findings presented at ObesityWeek…” Click here for full story.

WHO Launches First-Ever Insulin Prequalification Programme to Expand Access to Life-Saving Treatment for Diabetes

World Health Organization: “The World Health Organization (WHO) today announced the start of a pilot programme to prequalify human insulin to increase treatment for diabetes in low- and middle-income countries. The decision, announced ahead of World Diabetes Day (14 November), is part of a series of steps WHO will take to address the growing diabetes burden in all regions…” Click here for full story.

Diabetes: Why Some Anti-Inflammatories May Increase Risk

Medical News Today: “Doctors prescribe anti-inflammatory drugs long or short term to treat a range of conditions from allergies to arthritis. But could some of these drugs actually increase the risk for another chronic condition — diabetes?” Click here for full story.

Keeping Your Blood Sugar In Check Could Lower Your Alzheimer’s Risk

NPR: “Brain scientists are offering a new reason to control blood sugar levels: It might help lower your risk of developing Alzheimer’s disease. ‘There’s many reasons to get [blood sugar] under control,’ says David Holtzman, chairman of neurology at Washington University in St. Louis. ‘But this is certainly one…'” Click here for full story.

FDA Advisory Committee to Consider Lower-Dose Empagliflozin for Type 1 Diabetes

Healio: “The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA will vote today on whether to recommend approval of a supplemental new drug application for the SGLT2 inhibitor empagliflozin 2.5 mg as an oral medication adjunct to insulin therapy for adults with type 1 diabetes…” Click here for full story.

Week of November 6, 2019

Avocados May Help Prevent Diabetes

Science Daily: “Researchers have shown for the first time how a compound found only in avocados can inhibit cellular processes in the pancreas that normally lead to diabetes…” Click here for full story.

Diabetes Group Management With Low-Carb Diet As Effective As Increasing Medication

Healio: “In group medical visits for diabetes, adding intensive weight management with low-carbohydrate diets was as effective in improving blood sugar levels as conventional medication management, according to study results published in JAMA Internal Medicine…” Click here for full story.

‘I Wouldn’t Change It for the World’: Ravens TE Mark Andrews Not Slowed by Type 1 Diabetes in Breakout Season

USA Today: “Every time Mark Andrews jogs off the field between possessions in a game, he slips off his receiving gloves and pricks his finger. Then he does it again. And again. And maybe one more time, just to be sure…” Click here for full story.

‘No Difference Between the Diets’ In Reversing Prediabetes

Medscape: “The PREVIEW project is a multinational diabetes prevention project for which I was fortunate to be one of the principal investigators. It is funded by the European Union and includes six European countries plus Australia and New Zealand. We recruited 2300 people with proven prediabetes…” Click here for full story.

Researchers Engineer Insulin-Producing Cells Activated By Light for Diabetes

Phys.org: “Tufts University researchers have transplanted engineered pancreatic beta cells into diabetic mice, then caused the cells to produce more than two to three times the typical level of insulin by exposing them to light…” Click here for full story.

Nick Jonas Opens Up About Living with Type 1 Diabetes 14 Years After Diagnosis

People: “As Diabetes Awareness month kicks off on Friday, Nick Jonas is opening up about living with type 1 diabetes. The 27-year-old Jonas Brothers member and solo artist shared a candid Instagram post on Friday to discuss how getting diagnosed with type 1 diabetes 14 years ago…” Click here for full story.

Which Environmental Factors Affect Type 2 Diabetes Risk?

Medical News Today: “New research studies the association between environmental quality in over 3,000 United States counties and finds intriguing differences between rural and urban areas…” Click here for full story.

By Numbers, Cardiologists Well-Positioned for Diabetes Care

Medscape: “Cardiologists are well-placed to provide care for patients with type 2 diabetes, given their numbers and distribution relative to diabetes cases in the United States, new research suggests…” Click here for full story.

Week of October 31, 2019

Type 2 Diabetes Tied to Greater Risk for Vertebral, Nonvertebral Fractures

Healio: “Adults with type 2 diabetes are 55% more likely to sustain an incident vertebral fracture compared with adults without diabetes, with vertebral fracture history further raising the risk for experiencing a nonvertebral fracture, according to findings published in Diabetes Care…” Click here for full story.

Vitamin D Spray as Good as Oral Tablets in Raising Levels

Medscape: “For individuals who cannot or prefer not to take oral capsules, the same increase in vitamin D levels in the blood can be achieved with a sublingual spray, suggest the results of a small UK randomized controlled trial…” Click here for full story.

Increase Benefits of Exercise by Working Out Before Breakfast

Science Daily: “Exercising before eating breakfast burns more fat, improves how the body responds to insulin and lowers people’s risk of type 2 diabetes and cardiovascular disease…” Click here for full story.

A Trial For Kids At Risk Of Type 1 Diabetes Was Scaled Back, Leaving Families In Limbo

NPR: “At first, 19-year-old Sarah Hornak ignored the tingling in her hands and feet. She also ignored the 20 pounds of weight she shed, the constant hunger and thirst, the time she threw up after a tough workout. She went to her doctor only when she began to see halos everywhere…” Click here for full story.

Parents Speak Out After Son Dies From Type 1 Diabetes

ABC 12: “The parents of a 20-year-old East Carolina University student say a cure needs to be found after their son died from complications due to Type 1 diabetes…” Click here for full story.

Diabetics Being Treated with Thiazolidinediones May Be at Lower Risk of Parkinson’s, Study Suggests

Parkinsons News Today: “People with type 2 diabetes being treated with thiazolidinedione compounds, such as Actos (pioglitazone) and Avandia (rosiglitazone), may be at lower risk of Parkinson’s disease, a pilot study suggests. However, more work is needed to confirm a potential to prevent Parkinson’s in an at-risk patient population…” Click here for full story.

Diabetes Conference in Naples Brings Slate of Experts in Research and Care

Naples News: “Nine experts in diabetes prevention and treatment, some from leading universities, will be in Naples for an annual diabetes program Sunday. The fifth annual von Arx Family Foundation Southwest Florida Diabetes & Wellness Conference helps families and medical professionals learn what’s new in the disease…” Click here for full story.

Week of October 23, 2019

Diabetes Increases Risks for Certain Infections

Healio: “Adults with diabetes have increased risks for infections, such as influenza, cellulitis and sepsis, compared with adults without diabetes, according to findings published in Diabetes Care…” Click here for full story.

Limiting Mealtimes May Increase Your Motivation for Exercise

Science Daily: “Limiting access to food in mice increases levels of the hormone, ghrelin, which may also increase motivation to exercise, according to a new study. The study suggests that a surge in levels of appetite-promoting hormone, ghrelin, after a period of fasting prompted mice to initiate voluntary exercise…” Click here for full story.

Keeping Your Blood Sugar In Check Could Lower Your Alzheimer’s Risk

NPR: “Brain scientists are offering a new reason to control blood sugar levels: It might help lower your risk of developing Alzheimer’s disease. ‘There’s many reasons to get [blood sugar] under control,’ says David Holtzman, chairman of neurology at Washington University in St. Louis. ‘But this is certainly one…'” Click here for full story.

FDA Approves Dapagliflozin to Reduce HF Hospitalization in Diabetes

Medscape: “The type 2 diabetes drug dapagliflozin (Farxiga, AstraZeneca) has been approved in the United States for reducing hospitalization for heart failure (HF) in adults with type 2 diabetes and other cardiovascular (CV) risk factors, the company has announced…” Click here for full story.

Does the Rotavirus Vaccine Prevent Type 1 Diabetes?

Medical News Today: “Scientists have highlighted a possible link between infection with rotavirus and an increased risk of developing type 1 diabetes. Undergoing vaccination against the pathogen may be an effective way to prevent the condition…” Click here for full story.

Knowing Impacts of Diabetes, High School Student Raises Money for Friend to Get Diabetes Dog

Channel 3000: “As Diabetes Awareness Month approaches in November, a Darlington student is raising money for a life-changing helper. High school senior Lexi Graham deals with diabetes every day. It’s been a part of her world for nearly eight years, and she knows how it changes everything…” Click here for full story.

Balancing Game: Beau Corrales Excelling While Battling Diabetes

Inside Carolina: “When Beau Corrales was in the seventh grade, he remembers sitting in the back of his classroom trying to read the projector, but it wasn’t as easy as it always had been. His vision began to get blurry, which was confusing because he had always had perfect eyesight. Then, in his first football game of the season, he went to the bathroom before kickoff just like normal. He continued to have to go after warm-ups and again before the start of the second quarter….” Click here for full story.

Week of October 16, 2019

Earlier Introduction of Insulin May Improve Type 2 Diabetes Care for Some Patients

Healio: “Health care providers who treat patients with type 2 diabetes still need to include insulin among therapeutic options, and it may even be prudent to consider it earlier in the treatment process, according to a presenter at the Cardiometabolic Health Congress…” Click here for full story.

Endocrine Society Report Addresses Post-Meal Glucose in Diabetes

Medscape: “A new report from the Endocrine Society highlights the challenge of postprandial glucose management for people with insulin-requiring diabetes, providing some recommendations but also pointing out the major knowledge gaps…” Click here for full story.

Four Strategies to Obtain Affordable Insulin

Healio: “As the cost for insulin continues to rise, clinicians can take several proactive steps to help uninsured and underinsured patients afford their medications today, according to a speaker at the Cardiometabolic Health Congress…” Click here for full story.

Researchers Try A Genetic Diabetes Test To Prevent Emergency Hospitalizations

NPR: “Nearly half of all children who develop Type 1 diabetes don’t know they have the disease until they end up in a coma in the hospital. Researchers in Virginia have set out to see if a genetic test for Type 1 diabetes can eliminate many of those emergencies…” Click here for full story.

Shorter People More Likely to Develop Diabetes, Study Suggests

Chicago Tribune: “A poor diet and lack of exercise can lead to diabetes. But your height could also be a factor, according to a new report. Researchers from the German Institute of Human Nutrition recently conducted a study, published in the Diabetologia journal, to determine the association between height and Type 2 diabetes risk…” Click here for full story.

Patients With Diabetes Struggle With the Rising Cost of Insulin

The Courier: “Tessa McKenna can’t afford the $5,000 out-of-pocket deductible for the insulin that keeps her alive. A three-month supply of insulin — 10 vials — costs McKenna $2,700. ‘It’s really expensive…. The insurance that I’m on now is a high-deductible. It’s $5,000 for individual and $6,000 for family. Usually pharmacies want you to buy a three-month supply at a time,’ she said…” Click here for full story.

In Helping His Dad With Diabetes, Young Mexican Chemist Pioneers Healthy—and Cheap—Sugar Substitute

Good News Network: “When 18-year old Javier Larragoiti was told his father had been diagnosed with diabetes, the young man, who had just started studying chemical engineering at college in Mexico City, decided to dedicate his studies to finding a safe, sugar-alternative for his father…” Click here for full story.

Week of October 9, 2019

A1c Swings Tied to More Diabetes Complications Long Term

Medscape: “Patients with newly diagnosed type 2 diabetes who had highly variable A1c levels between visits were more likely to have macro- and microvascular complications of diabetes in long-term follow-up, a study shows…” Click here for full story.

Minorities Have Greater Diabetes Risk, Even With Normal and Low BMI

MedPage Today: “Certain racial and ethnic minorities, even at normal or below-normal body weight, were significantly more likely to have diabetes than whites, a large observational study demonstrated…” Click here for full story.

Diabetes Advances Poised to Help Manage Blood Sugar After Meals

Science Daily: “Mealtimes can become a difficult experience for individuals with diabetes. After a meal, blood sugar levels may soar as the food digests or unexpectedly plummet if an insulin dose was more than the meal required…” Click here for full story.

Scientists Who Discredited Meat Guidelines Didn’t Report Past Food Industry Ties

The New York Times: “A surprising new study challenged decades of nutrition advice and gave consumers the green light to eat more red and processed meat. But what the study didn’t say is that its lead author has past research ties to the meat and food industry…” Click here for full story.

Even Naturally Sweet Drinks May Increase Diabetes Risk

Medical News Today: “While researchers already knew that drinks with added sugar could increase a person’s risk of type 2 diabetes, a new study suggests that the same may be true for naturally sweet drinks, such as 100% fruit juices, as well as artificially sweetened beverages, such as “diet” soft drinks…” Click here for full story.

Weight Loss May Put Diabetes Into Remission

WebMD: “British researchers have good news for people with type 2 diabetes — you don’t need to lose a ton of weight to make a difference in your health…” Click here for full story.

Science Finds Simple Way to Lower Diabetes, High Blood Pressure Risk: Fiber

Healthline: “Fighting back against rising rates of type 2 diabetes and hypertension has been a losing battle for the medical community in the United States. Now, new research finds that adding fiber to your diet may help stave off these serious health conditions…” Click here for full story.

Diabetes Advances Poised to Help Manage Blood Sugar After Meals

Medical Xpress: “Mealtimes can become a difficult experience for individuals with diabetes. After a meal, blood sugar levels may soar as the food digests or unexpectedly plummet if an insulin dose was more than the meal required…” Click here for full story.

Week of October 2, 2019

FDA Approves Canagliflozin to Treat Diabetic Kidney Disease, Heart Failure Hospitalization

Healio: “The FDA approved a new indication for the SGLT2 inhibitor canagliflozin to reduce the risk for end-stage renal disease, worsening of kidney function, cardiovascular death and hospitalization for heart failure among adults with type 2 diabetes and diabetic kidney disease, according to a press release from Janssen…” Click here for full story.

Insulet’s Omnipod Dash Gets FDA Clearance As Integrated Insulin Pump

Smart Brief: “The FDA has cleared Insulet’s Omnipod Dash alternate controller-enabled infusion pump as an integrated insulin pump. The system can hold up to 200 units of U-100 insulin and features a touch-screen personal diabetes manager for control of the pod…” Click here for full story.

Child’s Gluten Intake During Infancy, Rather Than Mother’s During Pregnancy, Linked to Increased Risk of Developing Type 1 Diabetes

Science Daily: “New research shows that a child’s intake of gluten at age 18 months is associated with a 46% increased risk of developing type 1 diabetes for each extra 10g of gluten consumed…” Click here for full story.

‘A Bad Result’: A1C Targets Missed in Most With Type 1 Diabetes

Medscape: “Worldwide, only a small proportion of adults with type 1 diabetes are achieving optimal glucose control, new research indicates. Findings from the multinational, observational Study of Adults’ Glycemia in TID (SAGE) were presented September 17 here at the European Association for the Study of Diabetes (EASD) 2019 Annual Meeting…” Click here for full story.

Nick Jonas Says He Was Close To A Coma Before Diabetes Diagnosis

Refinery29: “Nick Jonas isn’t afraid to get real about his battle with type 1 diabetes. In an interview with Cigar Aficionado, he opened up about a close call he had when he was first diagnosed with the disease…” Click here for full story.

How Neuroscience Could Explain the Rise of Addictions, Heart Disease and Diabetes in 21st Century America

Time: “The conditions of human life began to improve with the Enlightenment of the 18th century, and we are better off now by many measures: food access, health, lifespan, and so on. But it hasn’t been an unbroken line of advancement…” Click here for full story.

Antidepressants Are Linked to a Higher Gestational Diabetes Risk in a New Study

CNN: “Taking antidepressants while pregnant may be associated with an increased risk of gestational diabetes, a new study suggests. It turned out that the increased risk appeared to be greatest for the two antidepressant drugs venlafaxine and amitriptyline, according to the study published in the journal BMJ Open on Tuesday. The study suggests a correlation but not causation…” Click here for full story.

Week of September 25, 2019

Gluten consumption during infancy tied to type 1 diabetes risk

healio: “Each 10 g of gluten consumed daily during infancy is associated with a 46% increased risk for developing type 1 diabetes during the next 12 years, whereas maternal gluten intake during pregnancy was not associated with future diabetes risk, according to study data presented at the European Association for the Study of Diabetes annual meeting.” Click here for the full story.

FDA OKs New Pill for Type 2 Diabetes

WebMD: “A new pill to lower blood sugar for people with type 2 diabetes was approved by the U.S. Food and Drug Administration on Friday.” Click here for the full story.

In People With Diabetes, What Really Matters Is Fat Mass Index, Not BMI

SciTech Daily: “In people with diabetes, fat mass index, not body mass index (BMI), is associated with a higher risk of cardiovascular events, according to new research in CMAJ (Canadian Medical Association Journal).” Click here for the full story.

Vitamin D deficiency linked with increased risk of death, particularly from diabetes: study

Yahoo!: “New European research has found that individuals with low levels of vitamin D may have a higher risk of an early death, particularly if they have diabetes.” Click here for the full story.

 

The latest delivered straight to your inbox

Learn More

Newsletter

Subscribe to Stay Informed

Sign up for Free

Get the latest diabetes news and a free gift!

Learn More

Save Your Favorites

Save This Article